Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications
AbstractSelection of inhibitor-resistant viral mutants is universal for viruses that display quasi-species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent results on drug resistance in HCV, with emphasis on resistance to the newly-developed, directly-acting antiviral agents, as they are increasingly employed in the clinic. We put the experimental observations in the context of quasi-species dynamics, in particular what the genetic and phenotypic barriers to resistance mean in terms of exploration of sequence space while HCV replicates in the liver of infected patients or in cell culture. Strategies to diminish the probability of viral breakthrough during treatment are briefly outlined. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Perales, C.; Quer, J.; Gregori, J.; Esteban, J.I.; Domingo, E. Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications. Viruses 2015, 7, 5746-5766.
Perales C, Quer J, Gregori J, Esteban JI, Domingo E. Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications. Viruses. 2015; 7(11):5746-5766.Chicago/Turabian Style
Perales, Celia; Quer, Josep; Gregori, Josep; Esteban, Juan I.; Domingo, Esteban. 2015. "Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications." Viruses 7, no. 11: 5746-5766.